Naslov
Interaction of estrogen and progesterone receptor and body mass index significantly changes the treatment outcome in HER+ breast cancer treated by endocrine therapy and trastuzumab; Croatian nested cross-sectional study
(Interaction of estrogen and progesterone receptor and body mass index significantly changes the treatment outcome in HER+ breast cancer treated by endocrine therapy and trastuzumab; Croatian nested cross-sectional study)

Autori
Pavlović, Mirjana ; Tečić Vuger, Ana ; Silovski, Tajana ; Jurić, Andreja ; Bajić, Žarko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
CEOC 2016 Book of Abstracts / - , 2016, 68-68

Skup
12th Central European Oncology Congress A Best of ASCO®

Mjesto i datum
Opatija, Hrvatska, 22.06.2016. - 25.06.2016

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
breast cancer, estrogen and progesterone receptors, BMI

Sažetak
Several studies indicated that estrogen receptor positive and progesterone receptor negative breast cancer patients have worse prognosis than patients with progesterone receptor positive tumors, but progesterone receptor status was not proven to be important predictive factor. The objective of our study was to find out whether there are demographic or clinical factors that may improve progesterone predictive validity in patients with estrogen and HER2 receptor positive breast cancers. In conclusion, interaction of estrogen, progesterone and body mass index significantly changes the treatment outcome in HER2+ breast cancer treated by endocrine therapy and trastuzumab

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA